GSK plc (GSK) reporting calendar
GSK plc files periodic reports with the SEC as GSK on NYSE. Atlas tracks 4 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 6 Mar 2026
- Reports on record
- 4
Open GSK market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 6 Mar 2026 | 65 days | 0001131399-26-000004 |
| 20-F | 31 Dec 2024 | 3 Mar 2025 | 62 days | 0001131399-25-000007 |
| 20-F | 31 Dec 2023 | 5 Mar 2024 | 65 days | 0001131399-24-000007 |
| 20-F | 31 Dec 2022 | 10 Mar 2023 | 69 days | 0001193125-23-067105 |
Source: SEC EDGAR company submissions for CIK 0001131399. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.